Technology, Healthcare, Financials Jan 18, 2022 04:39 PM (GMT+8) · EqualOcean
Cailian news agency, Jan. 18 (by wire) according to the announcement of Dizhe medicine, the company's pre IPO share lock held by the first largest shareholder advanced manufacturing industry investment fund (hereinafter referred to as "advanced manufacturing") and Astra Zeneca AB (hereinafter referred to as "azab") was extended for 6 months to June 9, 2025. The company's directors The lock of shares held by senior managers before the initial public offering of the company shall be extended for 6 months to January 15, 2024.

This text is a result of machine translation.